Literature DB >> 23371043

Distinguishing true from false positives in genomic studies: p values.

Linda Broer1, Christina M Lill, Maaike Schuur, Najaf Amin, Johannes T Roehr, Lars Bertram, John P A Ioannidis, Cornelia M van Duijn.   

Abstract

Distinguishing true from false positive findings is a major challenge in human genetic epidemiology. Several strategies have been devised to facilitate this, including the positive predictive value (PPV) and a set of epidemiological criteria, known as the "Venice" criteria. The PPV measures the probability of a true association, given a statistically significant finding, while the Venice criteria grade the credibility based on the amount of evidence, consistency of replication and protection from bias. A vast majority of journals use significance thresholds to identify the true positive findings. We studied the effect of p value thresholds on the PPV and used the PPV and Venice criteria to define usable thresholds of statistical significance. Theoretical and empirical analyses of data published on AlzGene show that at a nominal p value threshold of 0.05 most "positive" findings will turn out to be false if the prior probability of association is below 0.10 even if the statistical power of the study is higher than 0.80. However, in underpowered studies (0.25) with a low prior probability of 1 × 10(-3), a p value of 1 × 10(-5) yields a high PPV (>96 %). Here we have shown that the p value threshold of 1 × 10(-5) gives a very strong evidence of association in almost all studies. However, in the case of a very high prior probability of association (0.50) a p value threshold of 0.05 may be sufficient, while for studies with very low prior probability of association (1 × 10(-4); genome-wide association studies for instance) 1 × 10(-7) may serve as a useful threshold to declare significance.

Entities:  

Mesh:

Year:  2013        PMID: 23371043     DOI: 10.1007/s10654-012-9755-x

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  26 in total

1.  SNPs, haplotypes, and cancer: applications in molecular epidemiology.

Authors:  Timothy R Rebbeck; Christine B Ambrosone; Douglas A Bell; Stephen J Chanock; Richard B Hayes; Fred F Kadlubar; Duncan C Thomas
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-05       Impact factor: 4.254

2.  Gene-environment interactions: how many false positives?

Authors:  Giuseppe Matullo; Marianne Berwick; Paolo Vineis
Journal:  J Natl Cancer Inst       Date:  2005-04-20       Impact factor: 13.506

3.  A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints.

Authors:  Roger M Harbord; Matthias Egger; Jonathan A C Sterne
Journal:  Stat Med       Date:  2006-10-30       Impact factor: 2.373

4.  An unexpected influence of widely used significance thresholds on the distribution of reported P-values.

Authors:  J Ridley; N Kolm; R P Freckelton; M J G Gage
Journal:  J Evol Biol       Date:  2007-05       Impact factor: 2.411

5.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

6.  Effectiveness of strategies to increase the validity of findings from association studies: size vs. replication.

Authors:  Rolf Weitkunat; Etienne Kaelin; Grégory Vuillaume; Gerd Kallischnigg
Journal:  BMC Med Res Methodol       Date:  2010-05-28       Impact factor: 4.615

Review 7.  A comprehensive review of genetic association studies.

Authors:  Joel N Hirschhorn; Kirk Lohmueller; Edward Byrne; Kurt Hirschhorn
Journal:  Genet Med       Date:  2002 Mar-Apr       Impact factor: 8.822

8.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

9.  Fine mapping of five loci associated with low-density lipoprotein cholesterol detects variants that double the explained heritability.

Authors:  Serena Sanna; Bingshan Li; Antonella Mulas; Carlo Sidore; Hyun M Kang; Anne U Jackson; Maria Grazia Piras; Gianluca Usala; Giuseppe Maninchedda; Alessandro Sassu; Fabrizio Serra; Maria Antonietta Palmas; William H Wood; Inger Njølstad; Markku Laakso; Kristian Hveem; Jaakko Tuomilehto; Timo A Lakka; Rainer Rauramaa; Michael Boehnke; Francesco Cucca; Manuela Uda; David Schlessinger; Ramaiah Nagaraja; Gonçalo R Abecasis
Journal:  PLoS Genet       Date:  2011-07-28       Impact factor: 5.917

10.  STROBE-ME too!

Authors:  Cornelia M van Duijn
Journal:  Eur J Epidemiol       Date:  2011-10       Impact factor: 8.082

View more
  12 in total

1.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

2.  Genetics and brain morphology.

Authors:  Lachlan T Strike; Baptiste Couvy-Duchesne; Narelle K Hansell; Gabriel Cuellar-Partida; Sarah E Medland; Margaret J Wright
Journal:  Neuropsychol Rev       Date:  2015-03-14       Impact factor: 7.444

3.  GWAS of longevity in CHARGE consortium confirms APOE and FOXO3 candidacy.

Authors:  Linda Broer; Aron S Buchman; Joris Deelen; Daniel S Evans; Jessica D Faul; Kathryn L Lunetta; Paola Sebastiani; Jennifer A Smith; Albert V Smith; Toshiko Tanaka; Lei Yu; Alice M Arnold; Thor Aspelund; Emelia J Benjamin; Philip L De Jager; Gudny Eirkisdottir; Denis A Evans; Melissa E Garcia; Albert Hofman; Robert C Kaplan; Sharon L R Kardia; Douglas P Kiel; Ben A Oostra; Eric S Orwoll; Neeta Parimi; Bruce M Psaty; Fernando Rivadeneira; Jerome I Rotter; Sudha Seshadri; Andrew Singleton; Henning Tiemeier; André G Uitterlinden; Wei Zhao; Stefania Bandinelli; David A Bennett; Luigi Ferrucci; Vilmundur Gudnason; Tamara B Harris; David Karasik; Lenore J Launer; Thomas T Perls; P Eline Slagboom; Gregory J Tranah; David R Weir; Anne B Newman; Cornelia M van Duijn; Joanne M Murabito
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-09-08       Impact factor: 6.053

4.  GRASP: analysis of genotype-phenotype results from 1390 genome-wide association studies and corresponding open access database.

Authors:  Richard Leslie; Christopher J O'Donnell; Andrew D Johnson
Journal:  Bioinformatics       Date:  2014-06-15       Impact factor: 6.937

Review 5.  Sources of bias in genomics research of oral and dental traits.

Authors:  C S Agler; K Divaris
Journal:  Community Dent Health       Date:  2020-02-27       Impact factor: 1.349

6.  The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease.

Authors:  Christina M Lill; Aina Rengmark; Lasse Pihlstrøm; Isabella Fogh; Aleksey Shatunov; Patrick M Sleiman; Li-San Wang; Tian Liu; Christina F Lassen; Esther Meissner; Panos Alexopoulos; Andrea Calvo; Adriano Chio; Nil Dizdar; Frank Faltraco; Lars Forsgren; Julia Kirchheiner; Alexander Kurz; Jan P Larsen; Maria Liebsch; Jan Linder; Karen E Morrison; Hans Nissbrandt; Markus Otto; Jens Pahnke; Amanda Partch; Gabriella Restagno; Dan Rujescu; Cathrin Schnack; Christopher E Shaw; Pamela J Shaw; Hayrettin Tumani; Ole-Bjørn Tysnes; Otto Valladares; Vincenzo Silani; Leonard H van den Berg; Wouter van Rheenen; Jan H Veldink; Ulman Lindenberger; Elisabeth Steinhagen-Thiessen; Stefan Teipel; Robert Perneczky; Hakon Hakonarson; Harald Hampel; Christine A F von Arnim; Jørgen H Olsen; Vivianna M Van Deerlin; Ammar Al-Chalabi; Mathias Toft; Beate Ritz; Lars Bertram
Journal:  Alzheimers Dement       Date:  2015-04-30       Impact factor: 21.566

7.  Interpretation of gene associations with risk of acute respiratory distress syndrome: P values, Bayes factors, positive predictive values, and need for replication.

Authors:  Sebastian Rimpau; Ari R Joffe
Journal:  Crit Care       Date:  2016-12-21       Impact factor: 9.097

Review 8.  Assessing the utility of intermediate phenotypes for genetic mapping of psychiatric disease.

Authors:  Jonathan Flint; Nicholas Timpson; Marcus Munafò
Journal:  Trends Neurosci       Date:  2014-09-09       Impact factor: 13.837

9.  Integrative genomic analysis for the discovery of biomarkers in prostate cancer.

Authors:  Chindo Hicks; Tejaswi Koganti; Shankar Giri; Memory Tekere; Ritika Ramani; Jitsuda Sitthi-Amorn; Srinivasan Vijayakumar
Journal:  Biomark Insights       Date:  2014-06-29

10.  A targeted genetic association study of epithelial ovarian cancer susceptibility.

Authors:  Madalene Earp; Stacey J Winham; Nicholas Larson; Jennifer B Permuth; Hugues Sicotte; Jeremy Chien; Hoda Anton-Culver; Elisa V Bandera; Andrew Berchuck; Linda S Cook; Daniel Cramer; Jennifer A Doherty; Marc T Goodman; Douglas A Levine; Alvaro N A Monteiro; Roberta B Ness; Celeste L Pearce; Mary Anne Rossing; Shelley S Tworoger; Nicolas Wentzensen; Maria Bisogna; Louise Brinton; Angela Brooks-Wilson; Michael E Carney; Julie M Cunningham; Robert P Edwards; Zachary C Fogarty; Edwin S Iversen; Peter Kraft; Melissa C Larson; Nhu D Le; Hui-Yi Lin; Jolanta Lissowska; Francesmary Modugno; Kirsten B Moysich; Sara H Olson; Malcolm C Pike; Elizabeth M Poole; David N Rider; Kathryn L Terry; Pamela J Thompson; David van den Berg; Robert A Vierkant; Allison F Vitonis; Lynne R Wilkens; Anna H Wu; Hannah P Yang; Argyrios Ziogas; Catherine M Phelan; Joellen M Schildkraut; Yian Ann Chen; Thomas A Sellers; Brooke L Fridley; Ellen L Goode
Journal:  Oncotarget       Date:  2016-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.